Post-progression Therapies and Outcomes for Patients with Advanced, BRCA-related Pancreatic Cancer after Receipt of PARP Inhibitors: A National Retrospective Cohort Study.
JOURNAL OF CLINICAL ONCOLOGY（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要